These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2668446)

  • 1. Monoclonal antibody to embryonic CNS antigen A2B5 provides evidence for the involvement of membrane components at sites of Alzheimer degeneration and detects sulfatides as well as gangliosides.
    Majocha RE; Jungalwala FB; Rodenrys A; Marotta CA
    J Neurochem; 1989 Sep; 53(3):953-61. PubMed ID: 2668446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of A2B5-positive ganglioside in postmortem human brain tissue of Alzheimer disease, amyotrophic lateral sclerosis, progressive supranuclear palsy and control cases.
    Tooyama I; Yamada T; Kim SU; McGeer PL
    Neurosci Lett; 1992 Feb; 136(1):91-4. PubMed ID: 1321969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody A2B5, which detects cell surface antigens, binds to ganglioside GT3 (II3 (NeuAc)3LacCer) and to its 9-O-acetylated derivative.
    Dubois C; Manuguerra JC; Hauttecoeur B; Maze J
    J Biol Chem; 1990 Feb; 265(5):2797-803. PubMed ID: 2303428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogold labeling of Alzheimer paired helical filaments with ganglioside MAB A2B5.
    Clements JR; Beitz AJ; Emory CR; Frey WH
    Alzheimer Dis Assoc Disord; 1990; 4(1):35-42. PubMed ID: 2317336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganglioside monoclonal antibody (A2B5) labels Alzheimer's neurofibrillary tangles.
    Emory CR; Ala TA; Frey WH
    Neurology; 1987 May; 37(5):768-72. PubMed ID: 3574674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody to a plasma membrane antigen of neurons.
    Eisenbarth GS; Walsh FS; Nirenberg M
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4913-7. PubMed ID: 388422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell type specificity of a neural cell surface antigen recognized by the monoclonal antibody A2B5.
    Schnitzer J; Schachner M
    Cell Tissue Res; 1982; 224(3):625-36. PubMed ID: 7116415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody A2B5 reacts with many gangliosides in neuronal tissue.
    Fredman P; Magnani JL; Nirenberg M; Ginsburg V
    Arch Biochem Biophys; 1984 Sep; 233(2):661-6. PubMed ID: 6486807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of receptors for tetanus toxin and monoclonal antibody A2B5 by pancreatic islet cells.
    Eisenbarth GS; Shimizu K; Bowring MA; Wells S
    Proc Natl Acad Sci U S A; 1982 Aug; 79(16):5066-70. PubMed ID: 6750614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies specific for ganglion cells in the embryonic chicken neural retina.
    Cole GJ; Bond R; Glaser L
    Brain Res; 1986 Apr; 391(1):133-43. PubMed ID: 3513904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The monoclonal antibody A2B5 is specific to ganglioside GQ1c.
    Kasai N; Yu RK
    Brain Res; 1983 Oct; 277(1):155-8. PubMed ID: 6640289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of monoclonal antibody 3G5 and utilization of this antibody to immobilize pancreatic islet cell gangliosides in a solid phase radioassay.
    Powers AC; Rabizadeh A; Akeson R; Eisenbarth GS
    Endocrinology; 1984 Apr; 114(4):1338-43. PubMed ID: 6368201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody 18B8 detects gangliosides associated with neuronal differentiation and synapse formation.
    Grunwald GB; Fredman P; Magnani JL; Trisler D; Ginsburg V; Nirenberg M
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4008-12. PubMed ID: 3858858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical distribution of gangliosides in Alzheimer's disease.
    Kracun I; Kalanj S; Talan-Hranilovic J; Cosovic C
    Neurochem Int; 1992 Apr; 20(3):433-8. PubMed ID: 1304338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain gangliosides in Alzheimer's disease.
    Kracun I; Kalanj S; Cosovic C; Talan-Hranilovic J
    J Hirnforsch; 1990; 31(6):789-93. PubMed ID: 2092064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of monoclonal antibody A2B5 to gangliosides.
    Kundu SK; Pleatman MA; Redwine WA; Boyd AE; Marcus DM
    Biochem Biophys Res Commun; 1983 Nov; 116(3):836-42. PubMed ID: 6651849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane components separate early-onset Alzheimer's disease from senile dementia of the Alzheimer type.
    Gottfries CG; Karlsson I; Svennerholm L
    Int Psychogeriatr; 1996; 8(3):365-72. PubMed ID: 9116173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal and nonneuronal quantitative BACE immunocytochemical expression in the entorhinohippocampal and frontal regions in Alzheimer's disease.
    Leuba G; Wernli G; Vernay A; Kraftsik R; Mohajeri MH; Saini KD
    Dement Geriatr Cogn Disord; 2005; 19(4):171-83. PubMed ID: 15677864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody Tor 23 binds a subset of neural cells in the human cortex and displays an altered binding distribution in Alzheimer's disease.
    Kushner PD; Stephenson DT; Wright S; Cole GM; Greco CM
    J Neuropathol Exp Neurol; 1989 Nov; 48(6):692-708. PubMed ID: 2677253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the developing chick retina using monoclonal antibody 8A2 that recognizes a novel set of gangliosides.
    Drazba J; Pierce M; Lemmon V
    Dev Biol; 1991 May; 145(1):154-63. PubMed ID: 2019320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.